The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review
暂无分享,去创建一个
T. Barrick | A. Hainsworth | C. Kruuse | J. Isaacs | B. Moynihan | M. Pauls | J. Madigan
[1] Sandra E. Black,et al. Vascular cognitive impairment , 2018, Nature Reviews Disease Primers.
[2] A. Hainsworth,et al. Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: A systematic review of preclinical studies. , 2017, Cellular signalling.
[3] E. Rostrup,et al. Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial , 2017, Trials.
[4] Thalia Shoshana Field,et al. Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment , 2017, Journal of the American Heart Association.
[5] G. Jacob,et al. Nitric oxide-sensitive guanylyl cyclase signaling affects CO2-dependent but not pressure-dependent regulation of cerebral blood flow. , 2017, American journal of physiology. Regulatory, integrative and comparative physiology.
[6] M. Moss,et al. Translational models for vascular cognitive impairment: a review including larger species , 2017, BMC Medicine.
[7] Ian Marshall,et al. Cerebral blood flow in small vessel disease: A systematic review and meta-analysis , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] AS Elhwuegi. The Wonders of Phosphodiesterase-5 Inhibitors: A Majestic History , 2016, Annals of medical and health sciences research.
[9] C. Derdeyn,et al. Acute Effect of Intravenous Sildenafil on Cerebral Blood Flow in Patients with Vasospasm After Subarachnoid Hemorrhage , 2016, Neurocritical Care.
[10] Ian Marshall,et al. Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] M. Chicoine,et al. A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage. , 2016, Journal of neurosurgery.
[12] H. Markus,et al. Application of Diffusion Tensor Imaging Parameters to Detect Change in Longitudinal Studies in Cerebral Small Vessel Disease , 2016, PloS one.
[13] E. Rostrup,et al. Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy , 2016, Neurotherapeutics.
[14] E. Achten,et al. A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice , 2015, Neuroradiology.
[15] H. Markus,et al. Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study , 2015, PloS one.
[16] H. Markus,et al. The Brief Memory and Executive Test (BMET) for detecting vascular cognitive impairment in small vessel disease: a validation study , 2015, BMC Medicine.
[17] L. Bridges,et al. Endothelial Cells and Human Cerebral Small Vessel Disease , 2015, Brain pathology.
[18] Y. Lampl,et al. Regional cerebral blood flow following single‐dose and continuous‐dose tadalafil after stroke , 2014, Acta neurologica Scandinavica.
[19] David C. Anderson,et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial , 2014, The Lancet Neurology.
[20] M. Esiri,et al. PHOSPHODIESTERASE 5 (PDE5) AS A POTENTIAL THERAPEUTIC TARGET IN SMALL ARTERIES OF AGED HUMAN BRAINS , 2014, Alzheimer's & Dementia.
[21] M. Nelson,et al. Neurovascular signaling in the brain and the pathological consequences of hypertension. , 2014, American journal of physiology. Heart and circulatory physiology.
[22] Thomas M. Sanderson,et al. The role of phosphodiesterases in hippocampal synaptic plasticity , 2013, Neuropharmacology.
[23] E. Vicaut,et al. Cerebral and Extracerebral Vasoreactivity in Symptomatic Lacunar Stroke Patients: A Case-Control Study , 2013, International journal of stroke : official journal of the International Stroke Society.
[24] M. Dichgans,et al. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.
[25] J. Lanciego,et al. Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD , 2013, Neuropharmacology.
[26] M. Chopp,et al. Sildenafil Enhances Neurogenesis and Oligodendrogenesis in Ischemic Brain of Middle-Aged Mouse , 2012, PloS one.
[27] Wilhelm Kuker,et al. Increased Cerebral Arterial Pulsatility in Patients With Leukoaraiosis: Arterial Stiffness Enhances Transmission of Aortic Pulsatility , 2012, Stroke.
[28] W. M. van der Flier,et al. White Matter Lesion Progression in LADIS: Frequency, Clinical Effects, and Sample Size Calculations , 2012, Stroke.
[29] Marc Fisher,et al. Identifying and utilizing the ischemic penumbra , 2012, Neurology.
[30] M. Reinhard,et al. Cerebral autoregulation in acute ischemic stroke , 2012 .
[31] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[32] F. Al-amran,et al. Autonomic cerebral vascular response to sildenafil in diabetic patient , 2012, Diabetology & Metabolic Syndrome.
[33] S. Singh,et al. Safety and efficacy of sildenafil citrate in reversal of cerebral vasospasm: A feasibility study , 2012, Surgical neurology international.
[34] A. Cocchiarella. Partial motor restoration upon administration of sildenafil: a case study , 2012, Developmental neurorehabilitation.
[35] Charles DeCarli,et al. White matter hyperintensities and cognition: Testing the reserve hypothesis , 2011, Neurobiology of Aging.
[36] A. Lee,et al. Vascular Dementia , 2011, Chonnam medical journal.
[37] E. Karran,et al. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues , 2010, Neuropharmacology.
[38] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[39] Kirsten Shuler,et al. A Systematic Review of Dynamic Cerebral and Peripheral Endothelial Function in Lacunar Stroke Versus Controls , 2010, Stroke.
[40] I. Mena,et al. The effect of sildenafil citrate (Viagra) on cerebral blood flow in patients with cerebrovascular risk factors , 2009, Acta neurologica Scandinavica.
[41] P. Stoeter,et al. Sildenafil improves scotoma after posterior cerebral infarctions: a case report , 2010, Journal of Neurology.
[42] S. Finklestein,et al. Phosphodiesterase 5A Inhibitors Improve Functional Recovery after Stroke in Rats: Optimized Dosing Regimen with Implications for Mechanism , 2009, Journal of Pharmacology and Experimental Therapeutics.
[43] Norbert Schuff,et al. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging , 2009, Alzheimer's & Dementia.
[44] Frederik Barkhof,et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort , 2009, BMJ : British Medical Journal.
[45] A. Palmeri,et al. Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model , 2009, The Journal of Neuroscience.
[46] E. Rostrup,et al. Cerebral Haemodynamic Response or Excitability is not Affected by Sildenafil , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[47] P. Kelly,et al. Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats , 2009, Neuropsychopharmacology.
[48] T. Brown,et al. Regression algorithm correcting for partial volume effects in arterial spin labeling MRI , 2008, Magnetic resonance in medicine.
[49] L. Pantoni,et al. The relation between white-matter lesions and cognition , 2007, Current opinion in neurology.
[50] G. Mensah,et al. Vascular endothelium summary statement I: Health promotion and chronic disease prevention. , 2007, Vascular pharmacology.
[51] R. Tuder,et al. Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.
[52] H. Markus,et al. Asymmetric Dimethylarginine in Cerebral Small Vessel Disease , 2007, Stroke.
[53] K. Jellinger,et al. The enigma of vascular cognitive disorder and vascular dementia , 2007, Acta Neuropathologica.
[54] Donald H. Lee,et al. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. , 2006, Stroke.
[55] S. Brenner. Sildenafil increases cerebrovascular reactivity: A transcranial Doppler study , 2006, Neurology.
[56] W. Seeger,et al. Sildenafil Improves Dynamic Vascular Function in the Brain: Studies in Patients with Pulmonary Hypertension , 2006, Cerebrovascular Diseases.
[57] T. Fleming,et al. Sildenafil citrate therapy for pulmonary arterial hypertension. , 2005, The New England journal of medicine.
[58] J. Olesen,et al. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig. , 2005, European journal of pharmacology.
[59] Arthur R. Bradwell,et al. Effect of sildenafil and acclimatization on cerebral oxygenation at altitude. , 2005, Clinical science.
[60] H. Nukui,et al. Phosphodiesterase 5 inhibitor, zaprinast, selectively increases cerebral blood flow in the ischemic penumbra in the rat brain , 2005, Neurological research.
[61] J. Wharton,et al. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. , 2005, American journal of respiratory and critical care medicine.
[62] A. Hofman,et al. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.
[63] Jean-Jacques Moraine,et al. Effects of High Altitude Exposure on Cerebral Hemodynamics in Normal Subjects , 2005, Stroke.
[64] E. Fiumana,et al. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells , 2005, Basic Research in Cardiology.
[65] J. Corbin,et al. Mechanisms of action of PDE5 inhibition in erectile dysfunction , 2004, International Journal of Impotence Research.
[66] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[67] T. H. Klotz,et al. Sildenafil (Viagra®): Is there an influence on psychological performance? , 2004, International Urology and Nephrology.
[68] M. F. Goy,et al. mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain , 2003, The Journal of comparative neurology.
[69] Marc Fisher,et al. The Ischemic Penumbra: Identification, Evolution and Treatment Concepts , 2003, Cerebrovascular Diseases.
[70] F. Hofmann,et al. Individual Cerebellar Purkinje Cells Express Different cGMP Phosphodiesterases (PDEs): In Vivo Phosphorylation of cGMP-Specific PDE (PDE5) as an Indicator of cGMP-dependent protein kinase (PKG) Activation , 2003, The Journal of Neuroscience.
[71] K. Weissenborn,et al. Effect of sildenafil (Viagra®) on cerebral blood flow velocity: a pilot study , 2003, Psychiatry Research: Neuroimaging.
[72] Hugh S Markus,et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. , 2003, Brain : a journal of neurology.
[73] J. Olesen,et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. , 2003, Brain : a journal of neurology.
[74] A. Quyyumi,et al. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. , 2002, Journal of the American College of Cardiology.
[75] N. Pereira,et al. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. , 2002, The American journal of cardiology.
[76] J. Olesen,et al. The Phosphodiesterase 5 Inhibitor Sildenafil Has No Effect on Cerebral Blood Flow or Blood Velocity, but Nevertheless Induces Headache in Healthy Subjects , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[77] E Rostrup,et al. Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities , 2002, Stroke.
[78] C. Stein,et al. The effect of sildenafil on nitric oxide–mediated vasodilation in healthy men , 2001, Clinical pharmacology and therapeutics.
[79] N. Morrell,et al. Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension , 2001, Circulation.
[80] J. Olesen,et al. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation. , 2001, European journal of pharmacology.
[81] T. Münte,et al. Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials , 2001, World Journal of Urology.
[82] Ian G. McKeith,et al. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.
[83] H S Markus,et al. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI , 2000, Journal of neurology, neurosurgery, and psychiatry.
[84] T. Kitazono,et al. Role of potassium channels in cerebral blood vessels. , 1995, Stroke.
[85] D. Newell,et al. Comparison of static and dynamic cerebral autoregulation measurements. , 1995, Stroke.
[86] M. Nelson,et al. Physiological roles and properties of potassium channels in arterial smooth muscle. , 1995, The American journal of physiology.
[87] K. Hossmann. Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.
[88] H. Markus,et al. Estimation of Cerebrovascular Reactivity Using Transcranial Doppler, Including the Use of Breath‐Holding as the Vasodilatory Stimulus , 1992, Stroke.